Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies.

Sechi E, Krecke KN, Pittock SJ, Dubey D, Lopez-Chiriboga AS, Kunchok A, Weinshenker BG, Zalewski NL, Flanagan EP.

Mult Scler. 2020 Feb 27:1352458520907900. doi: 10.1177/1352458520907900. [Epub ahead of print]

PMID:
32103708
2.

Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD.

Arru G, Sechi E, Mariotto S, Zarbo IR, Ferrari S, Gajofatto A, Monaco S, Deiana GA, Bo M, Sechi LA, Sechi GP.

J Neuroimmunol. 2020 Jan 15;338:577110. doi: 10.1016/j.jneuroim.2019.577110. Epub 2019 Nov 6.

PMID:
31715457
3.

The frequency of longitudinally extensive transverse myelitis in MS: A population-based study.

Asnafi S, Morris PP, Sechi E, Pittock SJ, Weinshenker BG, Palace J, Messina S, Flanagan EP.

Mult Scler Relat Disord. 2020 Jan;37:101487. doi: 10.1016/j.msard.2019.101487. Epub 2019 Oct 31.

PMID:
31707235
4.

Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential.

Lepedda AJ, Deiana GA, Lobina O, Nieddu G, Baldinu P, De Muro P, Andreetta F, Sechi E, Arru G, Corda DG, Sechi GP, Formato M.

J Circ Biomark. 2019 Sep 11;8:1849454419875912. doi: 10.1177/1849454419875912. eCollection 2019 Jan-Dec.

5.

Unilateral motor progression in MS: Association with a critical corticospinal tract lesion.

Sechi E, Keegan BM, Kaufmann TJ, Kantarci OH, Weinshenker BG, Flanagan EP.

Neurology. 2019 Aug 13;93(7):e628-e634. doi: 10.1212/WNL.0000000000007944. Epub 2019 Jul 9.

PMID:
31289142
6.

Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology.

Sechi E, Shosha E, Williams JP, Pittock SJ, Weinshenker BG, Keegan BM, Zalewski NL, Lopez-Chiriboga AS, Jitprapaikulsan J, Flanagan EP.

Neurology. 2019 Jul 23;93(4):e414-e420. doi: 10.1212/WNL.0000000000007828. Epub 2019 Jun 24.

PMID:
31235660
7.

Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders.

Mariotto S, Ferrari S, Gastaldi M, Franciotta D, Sechi E, Capra R, Mancinelli C, Schanda K, Alberti D, Orlandi R, Bombardi R, Zuliani L, Zoccarato M, Benedetti MD, Tanel R, Calabria F, Rossi F, Pavone A, Grazian L, Sechi G, Batzu L, Murdeu N, Janes F, Fetoni V, Fulitano D, Stenta G, Federle L, Cantalupo G, Reindl M, Monaco S, Gajofatto A.

J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1293-1296. doi: 10.1136/jnnp-2018-320287. Epub 2019 Apr 5. No abstract available.

PMID:
30952681
8.

Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.

Mariotto S, Gajofatto A, Zuliani L, Zoccarato M, Gastaldi M, Franciotta D, Cantalupo G, Piardi F, Polo A, Alberti D, Sartori S, Zanusso G, Agrò L, Demurtas R, Sechi G, Sechi E, Monaco S, Ferrari S.

J Neurol. 2019 Jul;266(7):1643-1648. doi: 10.1007/s00415-019-09306-z. Epub 2019 Apr 3.

PMID:
30944980
9.

Diagnosis and Management of Autoimmune Dementia.

Sechi E, Flanagan EP.

Curr Treat Options Neurol. 2019 Feb 27;21(3):11. doi: 10.1007/s11940-019-0550-9. Review.

PMID:
30809732
10.

Hypertrophic olivary degeneration mimics relapse in neuromyelitis optica spectrum disorder.

Sechi E, Parks NE, Koeller KK, Flanagan EP.

Neurology. 2019 Feb 12;92(7):343-344. doi: 10.1212/WNL.0000000000006930. No abstract available.

PMID:
30745445
11.

Area postrema syndrome in autoimmune GFAP astrocytopathy.

Sechi E, Flanagan EP.

Mult Scler. 2020 Feb;26(2):255-256. doi: 10.1177/1352458519826489. Epub 2019 Jan 21. No abstract available.

PMID:
30663500
12.

Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.

Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP.

JAMA Neurol. 2019 Mar 1;76(3):301-309. doi: 10.1001/jamaneurol.2018.4053.

13.

Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis.

Sechi E, Morris PP, McKeon A, Pittock SJ, Hinson SR, Weinshenker BG, Aksamit AJ, Krecke KN, Kaufmann TJ, Jolliffe EA, Zalewski NL, Zekeridou A, Wingerchuk DM, Jitprapaikulsan J, Flanagan EP.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):488-490. doi: 10.1136/jnnp-2018-318004. Epub 2018 Jul 21. No abstract available.

PMID:
30032117
14.

Applying the 2017 McDonald diagnostic criteria for multiple sclerosis.

Sechi E, Keegan BM, Flanagan EP.

Lancet Neurol. 2018 Jun;17(6):498-499. doi: 10.1016/S1474-4422(18)30166-2. No abstract available.

PMID:
29778359
15.

Humoral immunity response to human endogenous retroviruses K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases.

Arru G, Mameli G, Deiana GA, Rassu AL, Piredda R, Sechi E, Caggiu E, Bo M, Nako E, Urso D, Mariotto S, Ferrari S, Zanusso G, Monaco S, Sechi G, Sechi LA.

Eur J Neurol. 2018 Aug;25(8):1076-e84. doi: 10.1111/ene.13648. Epub 2018 May 14.

PMID:
29603839
16.

Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder.

Bo M, Niegowska M, Arru G, Sechi E, Mariotto S, Mancinelli C, Farinazzo A, Alberti D, Gajofatto A, Ferrari S, Capra R, Monaco S, Sechi G, Sechi LA.

J Neuroimmunol. 2018 May 15;318:97-102. doi: 10.1016/j.jneuroim.2018.02.013. Epub 2018 Feb 28.

PMID:
29519720
17.

Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder.

Arru G, Sechi E, Mariotto S, Farinazzo A, Mancinelli C, Alberti D, Ferrari S, Gajofatto A, Capra R, Monaco S, Deiana GA, Caggiu E, Mameli G, Sechi LA, Sechi GP.

Mult Scler J Exp Transl Clin. 2017 Nov 22;3(4):2055217317742425. doi: 10.1177/2055217317742425. eCollection 2017 Oct-Dec.

18.

Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.

Mariotto S, Ferrari S, Monaco S, Benedetti MD, Schanda K, Alberti D, Farinazzo A, Capra R, Mancinelli C, De Rossi N, Bombardi R, Zuliani L, Zoccarato M, Tanel R, Bonora A, Turatti M, Calabrese M, Polo A, Pavone A, Grazian L, Sechi G, Sechi E, Urso D, Delogu R, Janes F, Deotto L, Cadaldini M, Bianchi MR, Cantalupo G, Reindl M, Gajofatto A.

J Neurol. 2017 Dec;264(12):2420-2430. doi: 10.1007/s00415-017-8635-4. Epub 2017 Oct 23.

19.

Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings.

Sechi E, Addis A, Batzu L, Mariotto S, Ferrari S, Conti M, Sechi G.

Mult Scler. 2018 Apr;24(5):685-688. doi: 10.1177/1352458517721661. Epub 2017 Aug 17.

PMID:
28814166
20.

Deciphering Molecular Mechanisms of Interface Buildup and Stability in Porous Si/Eumelanin Hybrids.

Pinna E, Melis C, Antidormi A, Cardia R, Sechi E, Cappellini G, d'Ischia M, Colombo L, Mula G.

Int J Mol Sci. 2017 Jul 19;18(7). pii: E1567. doi: 10.3390/ijms18071567.

21.

4-Nitrobenzene Grafted in Porous Silicon: Application to Optical Lithography.

Tiddia M, Mula G, Sechi E, Vacca A, Cara E, De Leo N, Fretto M, Boarino L.

Nanoscale Res Lett. 2016 Dec;11(1):436. doi: 10.1186/s11671-016-1654-8. Epub 2016 Sep 29.

22.

Paradoxical Effect of Levetiracetam in Newly Diagnosed Type II Focal Cortical Dysplasia.

Fois C, Rassu AL, Mandia D, Sechi E, Doneddu PE, Sechi G.

Clin Neuropharmacol. 2016 Sep-Oct;39(5):265-8. doi: 10.1097/WNF.0000000000000171.

PMID:
27404737
23.

Advances in clinical determinants and neurological manifestations of B vitamin deficiency in adults.

Sechi G, Sechi E, Fois C, Kumar N.

Nutr Rev. 2016 May;74(5):281-300. doi: 10.1093/nutrit/nuv107. Epub 2016 Mar 31. Review.

PMID:
27034475
24.

Longitudinally Extensive Spinal Cord Lesions Disclosing Occult Systemic Sarcoidosis.

Sechi E, Addis A, Piredda R, Rassu AL, Mameli G, Senes C, Sechi G.

JAMA Neurol. 2016 May 1;73(5):600-1. doi: 10.1001/jamaneurol.2016.0013. No abstract available.

PMID:
26974505
25.

Neuralgic amyotrophy mimicking Vernet syndrome.

Doneddu PE, Sechi E, Addis A, Fadda G, Fois C, Sechi G.

J Neurol Sci. 2016 Mar 15;362:230-1. doi: 10.1016/j.jns.2016.01.064. Epub 2016 Feb 2. No abstract available.

PMID:
26944154
26.

Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia.

Fancellu L, Borsini W, Romani I, Pirisi A, Deiana GA, Sechi E, Doneddu PE, Rassu AL, Demurtas R, Scarabotto A, Cassini P, Arbustini E, Sechi G.

BMC Neurol. 2015 Dec 12;15:256. doi: 10.1186/s12883-015-0513-z.

27.

Teaching NeuroImages: Subacute encephalopathy in a young woman with THTR2 gene mutation.

Sechi E, Addis A, Fadda G, Minafra L, Bravatà V, Sechi G.

Neurology. 2015 Oct 6;85(14):e108-9. doi: 10.1212/WNL.0000000000002002. No abstract available.

PMID:
26438623
28.

Clinicopathologic features of folate-deficiency neuropathy.

Sechi G, Fois C, Addis A, Sechi E.

Neurology. 2015 Sep 22;85(12):1090-1. doi: 10.1212/01.wnl.0000471972.90236.b6. No abstract available.

PMID:
26391416
29.

Involvement of IL-6 and IL-1 receptor antagonist on intellectual disability.

Aureli A, Sebastiani P, Del Beato T, Marimpietri AE, Graziani A, Sechi E, Di Loreto S.

Immunol Lett. 2014 Nov;162(1 Pt A):124-31. doi: 10.1016/j.imlet.2014.08.003. Epub 2014 Aug 11.

30.

Restless legs syndrome and cerebrovascular disease.

Sechi G, Sechi E.

Lancet Neurol. 2013 Aug;12(8):734. doi: 10.1016/S1474-4422(13)70106-6. No abstract available.

PMID:
23867193
31.

Ceftriaxone for Alexander's Disease: A Four-Year Follow-Up.

Sechi G, Ceccherini I, Bachetti T, Deiana GA, Sechi E, Balbi P.

JIMD Rep. 2013;9:67-71. doi: 10.1007/8904_2012_180. Epub 2012 Oct 13.

32.

Benign epilepsy of childhood with centro-temporal spikes (BECTS) versus migraine: a neuropsychological assessment.

Parisi P, Matricardi S, Tozzi E, Sechi E, Martini C, Verrotti A.

Childs Nerv Syst. 2012 Dec;28(12):2129-35. doi: 10.1007/s00381-012-1867-9. Epub 2012 Sep 8.

PMID:
22961355
33.

Attention-deficit hyperactivity disorder and intellectual disability: a study of association with brain-derived neurotrophic factor gene polymorphisms.

Aureli A, Del Beato T, Sebastiani P, Marimpietri A, Melillo CV, Sechi E, Di Loreto S.

Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):873-80.

PMID:
20943059
34.

Anatomical variability of the lateral femoral cutaneous nerve: findings from a surgical series.

Carai A, Fenu G, Sechi E, Crotti FM, Montella A.

Clin Anat. 2009 Apr;22(3):365-70. doi: 10.1002/ca.20766.

PMID:
19173255
35.

Holly's story: illustration of an attention deficit hyperactivity disorder case.

Aureli A, Piancatelli D, Del Beato T, Sebastiani P, Melillo V, Marimpietri A, Sechi E, Di Loreto S.

Int J Immunopathol Pharmacol. 2008 Oct-Dec;21(4):1049-51. No abstract available.

PMID:
19144294
36.

Investigation on the possible relationship existing between the HLA-DR gene and attention deficit hyperactivity disorder and/or mental retardation.

Aureli A, Sebastiani P, Del Beato T, Marimpietri A, Melillo V, Sechi E, Di Loreto S.

Int J Immunopathol Pharmacol. 2008 Oct-Dec;21(4):985-91.

PMID:
19144284
37.

Executive function impairment in early-treated PKU subjects with normal mental development.

Leuzzi V, Pansini M, Sechi E, Chiarotti F, Carducci C, Levi G, Antonozzi I.

J Inherit Metab Dis. 2004;27(2):115-25.

PMID:
15159642
38.

Nature of phonological delay in children with specific language impairment.

Orsolini M, Sechi E, Maronato C, Bonvino E, Corcelli A.

Int J Lang Commun Disord. 2001 Jan-Mar;36(1):63-90.

PMID:
11221434
39.

Reading strategies in children with learning disabilities and minor neurological dysfunction.

Levi G, Sechi E, Parisi C, Penge R.

Ital J Neurol Sci. 1986 Apr;Suppl 5:149-54.

PMID:
3759403
40.

Cognitive and linguistic strategies in children with reading disabilities in an oral storytelling test.

Levi G, Musatti L, Piredda ML, Sechi E.

J Learn Disabil. 1984 Aug-Sep;17(7):406-10. No abstract available.

PMID:
6481238
41.
42.

Language disorders and prognosis for reading disabilities in developmental age.

Levi G, Capozzi F, Fabrizi A, Sechi E.

Percept Mot Skills. 1982 Jun;54(3 Pt 2):1119-22.

PMID:
7110852
43.

[Tactile and kinetic recognition of numbers in children with specific reading disorders (preliminary note)].

Levi G, Sechi E, Bianchi P.

Riv Neurobiol. 1981 Jul-Dec;27(34):616-20. Italian. No abstract available.

PMID:
7052670
44.

[Subacute polyneuritis associated with chronic giardiasis (apropos of a case)].

Insola A, Pelli M, Sechi E, Sinibaldi L.

Riv Neurobiol. 1978 Jan-Jun;24(1-2):138-43. Italian. No abstract available.

PMID:
757643

Supplemental Content

Support Center